Literature DB >> 12865330

Mapping quantitative trait loci that influence serum insulin-like growth factor binding protein-5 levels in F2 mice (MRL/MpJ X SJL/J).

Subburaman Mohan1, Godfred Masinde, Xinmin Li, David J Baylink.   

Abstract

Recent studies using twins and inbred strains of mice reveal evidence for genetic mechanisms contributing to variation in circulating levels of IGF-I, IGF-II, and IGF binding protein (IGFBP)-3. To examine the hypothesis that serum IGFBP-5 levels have a strong heritable component, we intercrossed two inbred strains of mice, MRL/MpJ and SJL, which exhibit 79% difference in serum IGFBP-5 levels (554 +/- 68 vs. 309 +/- 51 ng/ml respectively, P < 0.001). A genome-wide scan was carried out using 137 polymorphic markers in 633 F2 female mice. Serum IGFBP-5 levels in the F2 progeny showed a normal distribution with an estimated heritability of 74%. Whole genome-wide scans for cosegregation of genetic marker data with high or low serum IGFBP-5 levels revealed six different quantitative trait loci (QTL) in chromosomes 1, 9 (two), 10, and 11 (two), which together explained 24% of F2 variance. Chromosome 11 QTL exhibited the highest LOD score (7.5). Based on the past findings that IGFBP-5 is an important bone formation stimulator, we predicted IGFBP-5 to contribute to bone mineral density variation in F2 mice. Accordingly, we found two of the six IGFBP-5 QTLs (Chrs 1 and 11) identified for serum IGFBP-5 phenotype also showed significant association with total body bone mineral density phenotype (measured by dual energy x-ray absorptiometry) in the F2 mice.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12865330      PMCID: PMC2904514          DOI: 10.1210/en.2003-0042

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  39 in total

1.  Insulin-like growth factor regulates peak bone mineral density in mice by both growth hormone-dependent and -independent mechanisms.

Authors:  Subburaman Mohan; Charmaine Richman; Rongqing Guo; Yousef Amaar; Leah Rea Donahue; Jon Wergedal; David J Baylink
Journal:  Endocrinology       Date:  2003-03       Impact factor: 4.736

2.  The complex of recombinant human insulin-like growth factor-I (rhIGF-I) and its binding protein-5 (IGFBP-5) induces local bone formation in murine calvariae and in rat cortical bone after local or systemic administration.

Authors:  F Bauss; K Lang; C Dony; L Kling
Journal:  Growth Horm IGF Res       Date:  2001-02       Impact factor: 2.372

Review 3.  Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions.

Authors:  S Rajaram; D J Baylink; S Mohan
Journal:  Endocr Rev       Date:  1997-12       Impact factor: 19.871

4.  Down-regulation of the serum stimulatory components of the insulin-like growth factor (IGF) system (IGF-I, IGF-II, IGF binding protein [BP]-3, and IGFBP-5) in age-related (type II) femoral neck osteoporosis.

Authors:  S Boonen; S Mohan; J Dequeker; J Aerssens; D Vanderschueren; G Verbeke; P Broos; R Bouillon; D J Baylink
Journal:  J Bone Miner Res       Date:  1999-12       Impact factor: 6.741

5.  Recombinant human insulin-like growth factor-binding protein-5 stimulates bone formation parameters in vitro and in vivo.

Authors:  C Richman; D J Baylink; K Lang; C Dony; S Mohan
Journal:  Endocrinology       Date:  1999-10       Impact factor: 4.736

6.  Genetic dissection of femur breaking strength in a large population (MRL/MpJ x SJL/J) of F2 Mice: single QTL effects, epistasis, and pleiotropy.

Authors:  Xinmin Li; Godfred Masinde; Weikuan Gu; Jon Wergedal; Subburaman Mohan; David J Baylink
Journal:  Genomics       Date:  2002-05       Impact factor: 5.736

7.  The complement component C1s is the protease that accounts for cleavage of insulin-like growth factor-binding protein-5 in fibroblast medium.

Authors:  W H Busby; T J Nam; A Moralez; C Smith; M Jennings; D R Clemmons
Journal:  J Biol Chem       Date:  2000-12-01       Impact factor: 5.157

8.  Effects of chronic renal failure and growth hormone on serum levels of insulin-like growth factor-binding protein-4 (IGFBP-4) and IGFBP-5 in children: a report of the Southwest Pediatric Nephrology Study Group.

Authors:  D R Powell; S K Durham; E D Brewer; J W Frane; S L Watkins; R J Hogg; S Mohan
Journal:  J Clin Endocrinol Metab       Date:  1999-02       Impact factor: 5.958

9.  Circulating levels of IGF-1 directly regulate bone growth and density.

Authors:  Shoshana Yakar; Clifford J Rosen; Wesley G Beamer; Cheryl L Ackert-Bicknell; Yiping Wu; Jun-Li Liu; Guck T Ooi; Jennifer Setser; Jan Frystyk; Yves R Boisclair; Derek LeRoith
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

10.  Growth hormone deficiency in 'little' mice results in aberrant body composition, reduced insulin-like growth factor-I and insulin-like growth factor-binding protein-3 (IGFBP-3), but does not affect IGFBP-2, -1 or -4.

Authors:  L R Donahue; W G Beamer
Journal:  J Endocrinol       Date:  1993-01       Impact factor: 4.286

View more
  8 in total

Review 1.  Molecular genetic studies of gene identification for osteoporosis: a 2004 update.

Authors:  Yong-Jun Liu; Hui Shen; Peng Xiao; Dong-Hai Xiong; Li-Hua Li; Robert R Recker; Hong-Wen Deng
Journal:  J Bone Miner Res       Date:  2006-10       Impact factor: 6.741

2.  A locus on mouse Chromosome 9 (Adip5) affects the relative weight of the gonadal but not retroperitoneal adipose depot.

Authors:  Amanda H McDaniel; Xia Li; Michael G Tordoff; Alexander A Bachmanov; Danielle R Reed
Journal:  Mamm Genome       Date:  2006-11-10       Impact factor: 2.957

3.  PAPPA2, an enzyme that cleaves an insulin-like growth-factor-binding protein, is a candidate gene for a quantitative trait locus affecting body size in mice.

Authors:  Julian K Christians; Andreas Hoeflich; Peter D Keightley
Journal:  Genetics       Date:  2006-05-15       Impact factor: 4.562

4.  Insulin-like growth factor-binding protein-5 induces a gender-related decrease in bone mineral density in transgenic mice.

Authors:  Dervis A M Salih; Subburaman Mohan; Yuji Kasukawa; Gyanendra Tripathi; Fiona A Lovett; Neil F Anderson; Emma J Carter; Jon E Wergedal; David J Baylink; Jennifer M Pell
Journal:  Endocrinology       Date:  2004-11-18       Impact factor: 4.736

5.  Percolation theory relates corticocancellous architecture to mechanical function in vertebrae of inbred mouse strains.

Authors:  Steven M Tommasini; Susan L Wearne; Patrick R Hof; Karl J Jepsen
Journal:  Bone       Date:  2007-12-28       Impact factor: 4.398

6.  Mouse BMD quantitative trait loci show improved concordance with human genome-wide association loci when recalculated on a new, common mouse genetic map.

Authors:  Cheryl L Ackert-Bicknell; David Karasik; Qian Li; Randy V Smith; Yi-Hsiang Hsu; Gary A Churchill; Beverly J Paigen; Shirng-Wern Tsaih
Journal:  J Bone Miner Res       Date:  2010-08       Impact factor: 6.741

7.  Genetically determined phenotype covariation networks control bone strength.

Authors:  Karl J Jepsen; Hayden-William Courtland; Joseph H Nadeau
Journal:  J Bone Miner Res       Date:  2010-07       Impact factor: 6.741

8.  Genetic randomization reveals functional relationships among morphologic and tissue-quality traits that contribute to bone strength and fragility.

Authors:  Karl J Jepsen; Bin Hu; Steven M Tommasini; Hayden-William Courtland; Christopher Price; Carl J Terranova; Joseph H Nadeau
Journal:  Mamm Genome       Date:  2007-06-08       Impact factor: 2.957

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.